Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Blood-derived CD34+ cells speed up healing, reduce scarring, and regrow hair in skin wounds.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Skin aging is due to impaired stem cell mobilization or fewer responsive stem cells.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Regulatory T cells are essential for normal and improved wound healing in mice.

Mast cells might contribute to hair loss by causing skin thickening.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Rhododendrol in skin-whitening products can cause skin depigmentation and immune reactions.

Hair follicle stem cells are a promising source for tissue repair and treating skin or hair diseases.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Wnt10b helps blood stem cells grow after injury.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Transplanting skin cells is a safe, effective, and affordable treatment for vitiligo.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

The research found genes that may protect certain scalp cells from hair loss.